Inovio Pharmaceuticals Inc (NAS:INO)
$ 4.32 0.13 (3.1%) Market Cap: 112.75 Mil Enterprise Value: 40.39 Mil PE Ratio: 0 PB Ratio: 1.53 GF Score: 46/100

Q2 2024 Inovio Pharmaceuticals Inc Earnings Call Transcript

Aug 08, 2024 / 08:30PM GMT
Release Date Price: $8.71 (+1.40%)
Operator

Good afternoon ladies and gentlemen and welcome to the Inovio second quarter 2024 financial results conference call. (Operator Instructions) This call is being recorded on Thursday, August 8, 2024. I would now like to turn the conference over to Thomas Hong, Manager of Investor Relations. Please go ahead.

Thomas Hong
Inovio Pharmaceuticals Inc - Manager, Investor Relations

Good afternoon and thank you for joining the Inovio second quarter 2024 financial results conference call. Joining me on today's call are, Dr. Jacque Shea, President and Chief Executive Officer; Dr. Michael Sumner, Chief Medical Officer; Peter Kies, Chief Financial Officer; and Steve Egge, Chief Commercial Officer. Today's call will review our corporate and financial information for the quarter ended June 30, 2024, as well as provide a general business update. Following prepared remarks, we will conduct a question-and-answer segment.

During the call, we'll be making forward-looking statements regarding future events and the future performance of the company. These events relate to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot